Geneva
The World Health Organization (WHO) urged countries on Friday to continue using the Oxford/AstraZeneca vaccine against COVID-19, as its benefits outweigh risks with tremendous potential to prevent infections and deaths from the pandemic.
Following the review on the AstraZeneca vaccine by WHO Global Advisory Committee on Vaccine Safety (GACVS), concerning blood clots and low platelets among some people vaccinated, the WHO has concluded that the available data do not suggest any overall increase in clotting conditions following administration of the vaccine, said WHO Director-General Tedros Adhanom Ghebreyesus at a press briefing.
“As a result, the committee has recommended that the AstraZeneca vaccine’s benefits outweigh its risks, with tremendous potential for preventing infections and deaths from COVID-19,” Tedros said.—Xinhua
